NEPHROTIC SYNDROME, TYPE 18
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in multiple components of the nuclear pore complex cause nephrotic syndrome.
|
30179222 |
2018 |
NEPHROTIC SYNDROME, TYPE 18
|
0.600 |
GeneticVariation
|
disease |
CLINVAR |
Mutations in multiple components of the nuclear pore complex cause nephrotic syndrome.
|
30179222 |
2018 |
NEPHROTIC SYNDROME, TYPE 18
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in multiple components of the nuclear pore complex cause nephrotic syndrome.
|
30179222 |
2018 |
NEPHROTIC SYNDROME, TYPE 18
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Homozygous splicing mutation in NUP133 causes Galloway-Mowat syndrome.
|
30427554 |
2018 |
NEPHROTIC SYNDROME, TYPE 18
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Galloway Mowat syndrome
|
0.310 |
GermlineCausalMutation
|
disease |
ORPHANET |
A nup133-knockdown zebrafish model exhibited microcephaly, fewer neuronal cells, underdeveloped glomeruli, and fusion of the foot processes of the podocytes, which mimicked human GAMOS features. nup133 morphants could be rescued by human wild-type NUP133 mRNA but not by mutant mRNA.
|
30427554 |
2018 |
Galloway Mowat syndrome
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Homozygous splicing mutation in NUP133 causes Galloway-Mowat syndrome.
|
30427554 |
2018 |
NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in multiple components of the nuclear pore complex cause nephrotic syndrome.
|
30179222 |
2018 |
Malignant neoplasm of breast
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Nephrotic Syndrome
|
0.110 |
AlteredExpression
|
group |
BEFREE |
On the other hand, nup133 downregulation results in proteinuria and moderate foot process effacement, mimicking some of the abnormalities typically featured by patients with nephrotic syndrome.
|
30894603 |
2019 |
Microcephaly
|
0.110 |
Biomarker
|
disease |
BEFREE |
A nup133-knockdown zebrafish model exhibited microcephaly, fewer neuronal cells, underdeveloped glomeruli, and fusion of the foot processes of the podocytes, which mimicked human GAMOS features. nup133 morphants could be rescued by human wild-type NUP133 mRNA but not by mutant mRNA.
|
30427554 |
2018 |
Microcephaly
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Nephrotic Syndrome
|
0.110 |
Biomarker
|
group |
HPO |
|
|
|
Dental Enamel Hypoplasia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dwarfism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Fetal Growth Retardation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Focal glomerulosclerosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hematuria
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Orbital separation excessive
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Kidney Diseases
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Micrognathism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Muscle Hypertonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Muscle hypotonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Proteinuria
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Seizures
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|